theory clinical_31_1
imports Main

begin

typedecl entity
typedecl event

consts
  BetaCatenin :: "entity ⇒ bool"
  Expression :: "entity ⇒ bool"
  Gene :: "entity ⇒ bool"
  CyclinD1 :: "entity ⇒ bool"
  CellProliferation :: "entity ⇒ bool"
  Activate :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  For :: "event ⇒ entity ⇒ bool"
  Mutation :: "entity ⇒ bool"
  CTNNB1 :: "entity ⇒ bool"
  Activity :: "entity ⇒ bool"
  Enhance :: "event ⇒ bool"
  LeadTo :: "event ⇒ event ⇒ bool"
  Increase :: "event ⇒ bool"
  Promote :: "event ⇒ bool"
  Proliferation :: "entity ⇒ bool"
  Via :: "event ⇒ entity ⇒ bool"
  Cell :: "entity ⇒ bool"

(* Explanation 1: β-catenin activates expression of many genes including cyclin D1 for cell proliferation. *)
axiomatization where
  explanation_1: "∃x y z e. BetaCatenin x ∧ Expression y ∧ Gene z ∧ CyclinD1 z ∧ CellProliferation y ∧ Activate e ∧ Agent e x ∧ Patient e y ∧ For e y"

(* Explanation 2: Activating mutations of CTNNB1 enhance the activity of β-catenin, leading to increased expression of genes like cyclin D1, which promotes cell proliferation. *)
axiomatization where
  explanation_2: "∃x y z w e1 e2. Mutation x ∧ CTNNB1 y ∧ Activity z ∧ BetaCatenin z ∧ Expression w ∧ Gene w ∧ CyclinD1 w ∧ CellProliferation w ∧ Enhance e1 ∧ Agent e1 x ∧ Patient e1 z ∧ LeadTo e1 e2 ∧ Increase e2 ∧ Promote e2 ∧ Agent e2 w ∧ Patient e2 w"

theorem hypothesis:
  assumes asm: "Mutation x ∧ CTNNB1 y ∧ Cell z ∧ BetaCatenin y"
  (* Hypothesis: Activating mutations of CTNNB1 promote proliferation of cells via β-catenin. *)
  shows "∃x y z e. Mutation x ∧ CTNNB1 y ∧ Cell z ∧ Proliferation z ∧ BetaCatenin y ∧ Promote e ∧ Agent e x ∧ Patient e z ∧ Via e y"
proof -
  (* From the premise, we have known information about Mutation, CTNNB1, Cell, and BetaCatenin. *)
  from asm have "Mutation x ∧ CTNNB1 y ∧ Cell z ∧ BetaCatenin y" by blast
  (* Explanation 2 provides a logical relation: Implies(D, E) and Implies(E, C). *)
  (* From Explanation 2, we know that activating mutations of CTNNB1 enhance the activity of β-catenin, leading to increased expression of genes like cyclin D1, which promotes cell proliferation. *)
  (* Therefore, we can infer that activating mutations of CTNNB1 lead to cell proliferation. *)
  then have "Proliferation z" sledgehammer
  (* We also know from Explanation 2 that this process involves promotion via β-catenin. *)
  (* Therefore, we can conclude that there exists an event e such that the mutation promotes proliferation via β-catenin. *)
  then have "∃e. Promote e ∧ Agent e x ∧ Patient e z ∧ Via e y" <ATP>
  then show ?thesis <ATP>
qed

end
